from Yahoo Finance https://ift.tt/2YXxVPV
-
LabCorp expands availability of at-home sample collection kit for COVID-19 testing
from Yahoo Finance https://ift.tt/2T1fHcN
-
U.S. FDA declines to review Bristol Myers, bluebird therapy for multiple myeloma
from Yahoo Finance https://ift.tt/2WUgWeC
The Latest
-
2 ASX ETFs that could be a perfect for a tech rally
-
National Australia Bank strengthens balance sheet ahead of 1H26 results
-
3 ASX dividend shares to buy for 5.8%, 7%, and 10% yields
-
NextDC reports 60% increase in contracted utilisation growth and higher capex guidance